2021
DOI: 10.1093/ve/veab103
|View full text |Cite
|
Sign up to set email alerts
|

Analyses of HIV proteases variants at the threshold of viability reveals relationships between processing efficiency and fitness

Abstract: Investigating the relationships between protein function and fitness provides keys for understanding biochemical mechanisms that underly evolution. Mutations with partial fitness defects can delineate the threshold of biochemical function required for viability. We utilized a previous deep mutational scan of HIV-1 protease (PR) to identify variants with 15-45% defects in replication and analyzed the biochemical function of eight variants (L10M, L10S, V32C, V32I, A71V, A71S, Q92I, Q92N). We purified each varian… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

3
2

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 58 publications
0
8
0
Order By: Relevance
“…Subsequently, compensatory mutations arise that rescue the enzyme defects caused by primary mutations; occasionally such mutations appear to also contribute to drug resistance both in HIV and SARS-CoV-2 in cell culture (Iketani et al 2022b; Zhou et al 2022; Kozisek et al 2007; Ragland et al 2017). In principle, mutations that increase enzymatic activity should provide a small growth advantage in the presence of drugs, and this might be amplified for viral proteases such as M pro which must cleave themselves out of polyproteins to generate additional active protease molecules (Schneider-Nachum et al 2021). The highest level of drug resistance observed in HIV protease and in SARS-CoV-2 M pro appears to arise from a combination of primary mutations that disrupt drug binding and compensatory mutations that increase enzyme activity.…”
Section: Introductionmentioning
confidence: 99%
“…Subsequently, compensatory mutations arise that rescue the enzyme defects caused by primary mutations; occasionally such mutations appear to also contribute to drug resistance both in HIV and SARS-CoV-2 in cell culture (Iketani et al 2022b; Zhou et al 2022; Kozisek et al 2007; Ragland et al 2017). In principle, mutations that increase enzymatic activity should provide a small growth advantage in the presence of drugs, and this might be amplified for viral proteases such as M pro which must cleave themselves out of polyproteins to generate additional active protease molecules (Schneider-Nachum et al 2021). The highest level of drug resistance observed in HIV protease and in SARS-CoV-2 M pro appears to arise from a combination of primary mutations that disrupt drug binding and compensatory mutations that increase enzyme activity.…”
Section: Introductionmentioning
confidence: 99%
“…The wide range of substrate cleavage rates led to the suggestion that the order of cleavage may be important for viral maturation [20, 21]. Recent studies [18, 22] indicate that the cutting rate of many sites can be altered dramatically without compromising fitness. However, the relationship between viral fitness and cutting efficiency has not been directly assessed for most cut sites.…”
Section: Introductionmentioning
confidence: 99%
“…19,20 The wide range of substrate cleavage rates led to the suggestion that the order of cleavage may be important for viral maturation. 21,22 Recent studies 19,23 indicate that the cutting rate of many sites can be altered dramatically without compromising fitness. However, the relationship between viral fitness and cutting efficiency has not been directly assessed for most cut sites.…”
Section: Introductionmentioning
confidence: 99%